Member Info for AquaeSulis01

Gigawitt " is a vey experienced litigant, a qualified company director and a qualified commercial design expert who fully appreciates the respective positions. The rest of you are clueless morons", curious why someone with that listed skillset and experience would provide so much free time trying to educate all us morons rather than earning more tens of thousands productively in the workplace?

Screenlearner, just trying to demonstrate that at the current sp there is virtually no downside risk and a lot of potential upside

Average PE for a growth tech company between 20-25

So accepting a $100M dollar net award after costs which equates to £81M, what market cap would you assign to a growth company with a tiny cash burn of £2.4M per annum and £86M cash in the bank?

Nice one elrico, it's ironic that phat's typical lack of analysis and sarcastic comment should provide an opportunity to reassure others who also failed to spot the x against "An event changing the breakdown of voting rights" in the RNS.

Gigawatt, happy to buy in at a pessimistic view of the award. Let's be very pessimistic and say after costs nanoco is left with £50M. They had £6.8M cash at year end with an annual cash burn of just £2.4M; their market cap at today's price is circa £119M and I can only imagine how a small company with such a low cash burn can use the funds to accelerate future growth of their other products. Now contrast this with Angle with a market cap of £77M, £32M cash at year end but an annual cash burn of £22M and revenue of just £1M; risky to buy in here, I don't think so?

Well you may be right in the long run but in the short term the market appears to disagree with you

You're missing the point draft, Bestway are seeking to secure an initial holding and add to it at the right price by offering to buy institutional holdings thus underpinning the share price. Institutions who have loaned shares to shorters may well now recall them

Should see the shorters rushing to close I would think

I must admit as a newbie to this share having bought in at the same price (37p) that the over subscribed placing took place at in June 2022, I am amazed that some pis have now jumped ship with the company now hugely derisked. Nought as strange as folk I suppose

"On 6 June 2022, the Company announced that it had raised £2.25m from a Placing and a Subscription for new shares at a price of 37 pence per share. A Broker Option opened at that time on the same terms and this closed at 5:00pm on 7 June 2022. The Company had indicated that the maximum number of shares to be issued would be 5% of the issued share capital immediately prior to the Fundraise (approximately £5.65m in total with a maximum of £3.40m from the Broker Option).



The Broker Option was very significantly over-subscribed. The Company has taken efforts to protect the participation requests from smaller retail investors and many of these will either not be scaled back or only modestly so. The balance of other participation requests have been scaled back after consultation with the Company's Joint Broker, Turner Pope Investments.



The total amount raised in the Fundraise, after scaling back over-subscriptions, amounts to £5.65m before costs of approximately £0.25m. FY22 year end cash is therefore expected to be between £7.0m and £7.5m. The additional funding from the Broker Option extends the Company's cash runway into CY25, well beyond the point that the Company expects the organic business to be profitable and cash generative. The significant value inflection point in the Samsung IP litigation trial, now due in September 2022, was already covered by the Placing and Subscription. The cash runway now extends even further and beyond the expected outcome of Samsung's appeals against the decisions in Nanoco's favour by the Patent Trial and Appeal Board on the validity of all 47 of Nanoco's claims in the litigation."

Quentin Tarantino would be quite appropriate as there as certainly been a lot of blood on the floor with this share. Perhaps some of us older LTH's could be employed as extras sporting the menacing ad tee shirts that regularly pop-up on this site when I access it that state "Don't p 1 ss old people off as time in detention is less of a deterrent as you get older"

Another very good update from First Class Metals today. Reminder that POW holds a 28% interest in FCM which at IPO at 10p equated to £1.85 M , the share price today is nearly 43% higher at 14.35p so anpreciating asset.

directors talk net

https://*************.net/

Gigawitt, I know the second RNS put a dampener on things but worth noting that Edison, the paid for mouthpiece for Nanoco, did not change their estimate on the basis of their estimate for Nanoco despite the second RNS
https://*************.net/context-on-no-fault-settlement-of-litigation
Nanoco’s regulatory news release gives more information on its proposed settlement with Samsung and adds useful context in the face of speculation on investor forums and share price volatility after the 6 January no-settlement announcement. Nanoco expects to issue another update when it completes the final binding agreement within the next 30 days. We leave our estimates unchanged.

skid you are of course quite correct. For me personally it will feel like "free money" because I still haven't had the listing through for my dividend shares from H&L so they have been sat in my account at nil value for months on end, and also I was fortunate enough to sell my Opti holding immediately on qualifying at 37p before buying back in in the 18s and 14s.
Rather frustratingly H&L wont let me deal PBX online currently else sorely tempted to buy at the current price although difficulty in trading is no doubt a major contributor to the ludicrous share price shown

Acne improvements first noticed during the Bright Study and the fact axis is being further refined to address acne specifically should make the upcoming study a formality. The real issue isn't t will it work spectacularly well but can we market it far more effectively than we did for psoriasis. This from end of year results RNS "Acne

The next product in development under the AsixBiotix pillar is one targeting acne. Early signs of efficacy were seen in the participant study with benefits reported by people suffering from other conditions, from acne, rosacea and eczema.



During the year, the Group has been developing a new bacterial blend. Management is pleased to report that the pilot formulation is stable and it is looking to design a consumer study in the same form as the BRIGHT study for Axis-Biotix-Ps™. This study is anticipated to commence during 2023. In the meantime, the team is assessing the options for the most appropriate commercialisation strategy, on the basis of a positive outcome."

martinu, with Opti holding 44% and SOH a further 5% no vulture will be able to acquire this at less than SOH believes it is worth

Will be holding on to my probiotix freebies as well, we have been told trading has been strong, results likely in Feb and in the first Dec podcast SOH did, interesting he spoke of the possibility of Probiotix being acquired (Seed Health or the newly combined Firmenich/DSM would be prime candidates) which should underpin any further share price slide.
https://soundcloud.com/optibiotix-investor about 18:24 in

mol, to be honest I can't get too exasperated by some pictures of pottery at the bottom of the link, and I am surprised that someone as astute as yourself missed the real faux pas here which is the Go Figure Porridge plug when Opti no longer sell it on their site!